FBT
EBS icon

First Bank & Trust’s Emergent Biosolutions EBS Stock Holding History

First Bank & Trust’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,847
Closed -$57K – 264
2022
Q2 		$57K Sell
1,847
-254
-12% -$8.67K 0.02% 277
2022
Q1 		$86K Buy
2,101
+251
+14% +$11.1K 0.03% 264
2021
Q4 		$81K Buy
1,850
+452
+32% +$20.4K 0.03% 251
2021
Q3 		$70K Hold
1,398
– – 0.03% 253
2021
Q2 		$88K Sell
1,398
-545
-28% -$35K 0.04% 244
2021
Q1 		$181K Buy
1,943
+343
+21% +$35.1K 0.09% 170
2020
Q4 		$143K Sell
1,600
-669
-29% -$61.4K 0.09% 168
2020
Q3 		$234K Sell
2,269
-786
-26% -$84.7K 0.16% 118
2020
Q2 		$242K Buy
3,055
+1,295
+74% +$96.5K 0.18% 110
2020
Q1 		$102K Buy
1,760
+711
+68% +$41K 0.09% 164
2019
Q4 		$57K Buy
1,049
+962
+1,106% +$52.2K 0.04% 233
2019
Q3 		$5K Hold
87
– – ﹤0.01% 336
2019
Q2 		$4K Buy
+87
New +$4.17K ﹤0.01% 334

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

First Bank & Trust's EBS Position: Q3 2022 in Review

First Bank & Trust sold out of Emergent Biosolutions (EBS) in Q3 2022, closing a stake of 1,847 shares — an estimated $57K sold.

First Bank & Trust first reported a position in EBS in Q2 2019 and held it in 13 quarters. The position peaked at $242K in Q2 2020. 211 funds tracked by Wall St. Rank hold EBS as of Q3 2022.

  • First Bank & Trust reported no remaining Emergent Biosolutions position as of Q3 2022 after selling out during the quarter.
  • First Bank & Trust sold 1,847 Emergent Biosolutions shares in Q3 2022, an estimated $57K.
  • First Bank & Trust first reported a position in Emergent Biosolutions in Q2 2019 and held it in 13 quarters.
  • First Bank & Trust's Emergent Biosolutions position peaked at $242K in Q2 2020.
  • 211 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2022.

Based on First Bank & Trust's 13F filing for Q3 2022, filed 28 Oct 2022.